Amgen (AMGN) PT Raised to $240 at BMO Capital; Otezla Deal 'Makes Strategic Sense'
Tweet Send to a Friend
BMO Capital analyst Do Kim raised the price target on Amgen (NASDAQ: AMGN) to $240.00 (from $230.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
